The Latest Cardiac and Vascular News
Time to throw in the towel for Abbott on this generation of their Absorb BVS because of slow sales. However, there could still be a platform for this technology… Abbott halts global sales of 1st-gen Absorb stents SEPTEMBER 8, 2017 BY FINK DENSFORD , MassDevice Abbott (NYSE:ABT) said today it will halt global sales […]
NEWTOWN, Pa., Sept. 7, 2017 /PRNewswire/ — Micro Interventional Devices, Inc.(MID) has successfully completed the first in human tricuspid valve bicuspidization procedure utilizing its MIA (Minimally Invasive Annuloplasty) technology. The successful bicuspidization resulted in a 34.5% reduction in valve area, reducing the patient’s tricuspid regurgitation from severe/moderate to trace. The patient was the […]
Erlangen, 2016-Sep-27 Somatom Confidence RT Pro is a dedicated CT for radiation therapy DirectDensity algorithm delivers electron density images independent of kV settings, ensuring a smooth simple dose calculation workflow New version of syngo.via RT Image Suite software offers advanced treatment of moving tumors Siemens Healthineers introduced its new Somatom […]
SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. [OTC:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, with clinical programs in heart failure and sub-acute infarction, today announced the issuance of United States Patent No. 9,301,975 relating to a method of producing mesenchymal stem cells from bone marrow cells in […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a U.S. developer of wearable medical devices and diagnostic software, announced today that the company continues to experience a steady beat of market traction and industry endorsement with a recent infusion of $4.5 million into their new C-1 round of funding, currently capped at $10 […]
LAKE FOREST, Calif., Aug. 30, 2017 – NaviGate Cardiac Structures Inc. (“NCSI”) announced today that its GATE™ catheter-guided tricuspid atrioventricular valved stent (A VS) was implanted through the jugular vein six weeks ago into a patient’s transplanted heart that was failing due to severe tricuspid valve insufficiency. The successful implantation […]
MOUNTAIN VIEW, Calif., Sept. 01, 2017 (GLOBE NEWSWIRE) — Vascular Dynamics, Inc. (VDI), a privately held medical device company developing novel solutions for the treatment of hypertension, today announced European results of the company’s first-in-human trial of its MobiusHD®implant published in The Lancet. The publication reported an average reduction of 24-hour […]
VANCOUVER, Sept. 5, 2017 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company“) (NASDAQ, TSX: NVCN) today announced the European Heart Journal published a clinical review of its Neovasc Reducer™ (“Reducer”) device for the treatment of refractory/persistent angina pectoris, a common and disabling medical condition, and a major public health problem that affects […]
AACHEN, Germany–(BUSINESS WIRE)–Protembis GmbH, a privately held medical device company, announced today the first clinical applications of its ProtEmbo® Cerebral Protection System to complement a transcatheter aortic valve replacement (TAVR) procedure. The ProtEmbo® System is an intra-aortic filter device that deflects embolic material arising during TAVR away from the brain. Darren Mylotte, […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that Anthem Blue Cross Blue Shield, Blue Shield of California, and Blue Cross and Blue Shield of Alabama have each issued a positive medical policy for the HeartFlow® FFRct Analysis, a first-of-its-kind noninvasive technology that helps clinicians diagnose and treat patients with suspected coronary artery […]
